Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EPLIN, epithelial protein lost in neoplasm.

R S Maul1, D D Chang

  • 1Department of Medicine, Jonnson Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles, California, CA 90095, USA.

Oncogene
|January 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.

Human molecular genetics·2001
Same author

Characterization of mouse epithelial protein lost in neoplasm (EPLIN) and comparison of mammalian and zebrafish EPLIN.

Gene·2001
Same author

Differential gene expression between normal and tumor-derived ovarian epithelial cells.

Cancer research·2000
Same author

Overexpression of wild-type RhoA produces growth arrest by disrupting actin cytoskeleton and microtubules.

Journal of cellular biochemistry·2000
Same author

Characterization of the human EPLIN (Epithelial Protein Lost in Neoplasm) gene reveals distinct promoters for the two EPLIN isoforms.

Gene·2000
Same author

Identification of a cell type-specific enhancer in the distal 5'-region of the platelet-derived growth factor A-chain gene.

The Journal of biological chemistry·1998
Same journal

SRD5A3-mediated aberrant N-glycosylation of SCARA5 promotes ferroptosis in lung adenocarcinoma.

Oncogene·2026
Same journal

Aberrant splicing in human cancer shows possible functional impact on transcription factors.

Oncogene·2026
Same journal

The crosstalk between RNA m6A modification and protein lactylation: emerging insights into tumor progression.

Oncogene·2026
Same journal

Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.

Oncogene·2026
Same journal

Amphiregulin-mediated EGFR activation drives both intrinsic and acquired resistance to KRAS G12C inhibitors in KRAS G12C-mutant non-small cell lung cancer.

Oncogene·2026
Same journal

Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.

Oncogene·2026
See all related articles

Researchers discovered Epithelial Protein Lost In Neoplasm (EPLIN), a novel cytoskeletal protein. Loss of EPLIN expression in cancer cells may contribute to tumor progression, highlighting its potential role in neoplasm development.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Epithelial cells form the lining of many organs and tissues.
  • Cytoskeletal proteins play crucial roles in cell structure, migration, and division.
  • Alterations in protein expression are common in cancer development.

Purpose of the Study:

  • To identify and characterize a novel cytoskeletal protein, EPLIN.
  • To investigate the expression pattern of EPLIN in normal and cancerous epithelial cells.
  • To explore the functional role of EPLIN in cell proliferation.

Main Methods:

  • Protein identification and characterization.
  • Quantitative analysis of EPLIN expression in various cancer cell lines and xenograft tumors.
  • Overexpression studies to assess the effect on cell proliferation.

Related Experiment Videos

  • Immunofluorescence to determine protein localization.

    • Main Results:

    • A novel cytoskeletal protein, EPLIN, was identified and found to have two isoforms (EPLIN-alpha and EPLIN-beta).
    • EPLIN is preferentially expressed in normal human epithelial cells from oral mucosa, prostate, and mammary glands.
    • EPLIN-alpha expression was significantly down-regulated or lost in the majority of oral, prostate, and breast cancer cell lines and tumors analyzed.
    • Both EPLIN isoforms localize to filamentous actin and inhibit cell proliferation when overexpressed.

    Conclusions:

    • The loss or down-regulation of EPLIN in cancer cells suggests it may function as a tumor suppressor.
    • EPLIN's role in suppressing cell proliferation indicates its potential involvement in preventing uncontrolled cell growth in neoplasms.
    • Further research into EPLIN's functions could reveal new therapeutic targets for epithelial cancers.